Mortality in patients with left ventricular ejection fraction </=30% after primary percutaneous coronary intervention

Jan Paul Ottervanger1, Anand R Ramdat Misier, Jan-Henk E Dambrink

  • 1Department of Cardiology, Isala klinieken, Zwolle, The Netherlands. v.r.c.derks@isala.nl

Insights

Patients with reduced left ventricular (LV) function after heart attack and primary percutaneous coronary intervention have better survival than previously thought. This suggests a need to re-evaluate the routine use of implantable cardioverter-defibrillators (ICDs) in this population.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Decreased left ventricular (LV) function is a significant predictor of mortality following myocardial infarction.
  • Current guidelines suggest prophylactic implantable cardioverter-defibrillator (ICD) implantation for patients with ST-elevation myocardial infarction and LV ejection fraction ≤30% after one month.
  • Improved reperfusion therapies and increased use of life-saving medications may alter the prognosis of these patients compared to historical ICD trials.

Purpose of the Study:

  • To prospectively assess the 1-year mortality rate in patients with depressed LV ejection fractions after primary percutaneous coronary intervention (PCI).
  • To compare current outcomes with historical data from randomized trials of ICDs in similar patient populations.

Main Methods:

  • A prospective, observational study was conducted.
  • Data were collected from patients who survived at least 30 days after primary PCI and had an LV ejection fraction (LVEF) of ≤30% between 1994 and 2004.
  • One-year mortality and causes of death were analyzed.

Main Results:

  • Out of 2,544 patients, 342 (13%) had an LVEF ≤30%.
  • The 1-year mortality rate in this cohort was 5.8%.
  • Sudden death was the most frequent cause of mortality (40%), often associated with multivessel disease and recurrent myocardial infarction within the first year.

Conclusions:

  • One-year mortality for patients with depressed LV function after primary PCI is lower than previously reported in major ICD trials.
  • The findings suggest that the benefits of prophylactic ICD therapy in this specific patient group warrant further investigation and re-evaluation.
  • Improved contemporary medical and interventional management may be contributing to better outcomes.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...